![Hugh Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hugh Davis
Präsident bei
ACLARIS THERAPEUTICS, INC.
Vermögen: 206 684 $ am 31.05.2026
Profil
Dr. Hugh M.
Davis is a President, Chief Operating Officer & Director at Aclaris Therapeutics, Inc. He is on the Board of Directors at Aclaris Therapeutics, Inc. Dr. Davis was previously employed as a President, Chief Business & Development Officer by Biosion, Inc., a Chief Business Officer by Frontage Holdings Corp., and a Vice President-Clinical Pharmacology by Janssen Research & Development LLC.
He received his undergraduate degree from Gannon University and a doctorate degree from Villanova University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2026 | 45’425 ( 0.03% ) | 206 684 $ | 31.05.2026 |
Aktive Positionen von Hugh Davis
| Unternehmen | Position | Beginn |
|---|---|---|
| ACLARIS THERAPEUTICS, INC. | Präsident | 18.11.2024 |
Ehemalige bekannte Positionen von Hugh Davis
| Unternehmen | Position | Ende |
|---|---|---|
| FRONTAGE HOLDINGS CORPORATION | Corporate Officer/Principal | 01.03.2020 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | 01.01.2018 |
Biosion, Inc.
 Biosion, Inc. BiotechnologyHealth Technology Engages in research and development of antibody drugs | Präsident | - |
Ausbildung von Hugh Davis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Aclaris Therapeutics, Inc.
 Aclaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel drug candidates for immuno-inflammatory diseases | Health Technology |
Gannon University
 Gannon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Frontage Holdings Corp.
 Frontage Holdings Corp. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Biosion, Inc.
Biosion, Inc. BiotechnologyHealth Technology Engages in research and development of antibody drugs | Health Technology |
